Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment

BACKGROUND: After development of hormone-refractory metastatic disease, prostate cancer is incurable. The recent history of chemotherapy has shown that with difficult disease targets, combinatorial therapy frequently offers the best chance of a cure. In this study we have examined the effects of a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Brubaker, Kristen D, Brown, Lisha G, Vessella, Robert L, Corey, Eva
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360086/
https://www.ncbi.nlm.nih.gov/pubmed/16417633
http://dx.doi.org/10.1186/1471-2407-6-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360086/
https://www.ncbi.nlm.nih.gov/pubmed/16417633
http://dx.doi.org/10.1186/1471-2407-6-15

Ejemplares similares